9 companies

Novo Nordisk

Market Cap: DKK 1.1t

Engages in the research and development, manufacture, and distribution of pharmaceutical products.

NOVO B

DKK 238.10

7D

0.5%

1Y

-41.9%

Genmab

Market Cap: DKK 110.7b

A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.

GMAB

DKK 1,802.50

7D

2.5%

1Y

48.1%

ALK-Abelló

Market Cap: DKK 46.0b

An allergy solutions company, develops treatments for respiratory allergy, anaphylaxis, and food allergy and new disease areas in the European Union, the United Kingdom, Norway, Switzerland, the United States, Canada, Japan, China, and internationally.

ALK B

DKK 207.60

7D

0.9%

1Y

51.1%

H. Lundbeck

Market Cap: DKK 38.2b

Engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally.

HLUN B

DKK 39.84

7D

-2.3%

1Y

41.7%

Zealand Pharma

Market Cap: DKK 21.0b

A biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States.

ZEAL

DKK 296.80

7D

-0.4%

1Y

-30.8%

Bavarian Nordic

Market Cap: DKK 15.0b

Develops, manufactures, and supplies life-saving vaccines.

BAVA

DKK 194.60

7D

-0.6%

1Y

33.7%

Gubra

Market Cap: DKK 5.5b

A disease-agnostic techbio company, focuses on the peptide-based drug discovery and preclinical contract research services in Europe, North America, and internationally.

GUBRA

DKK 338.00

7D

-7.2%

1Y

-10.3%

ChemoMetec

Market Cap: DKK 5.2b

Engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally.

CHEMM

DKK 300.20

7D

-2.8%

1Y

-33.4%

Strategic Partners

Market Cap: DKK 25.9m

Does not have significant operations.

STRAP

DKK 620.00

7D

2.0%

1Y

-40.1%